ScholarLens Back to search
2016•Modern PathologyOpen access

Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation

Paul W. Harms, Angela M. B. Collie, Daniel H. Hovelson, Andi K. Cani, Monique Verhaegen, Rajiv M. Patel, Douglas R. Fullen, Kei Omata, Andrzej A. Dlugosz, Scott A. Tomlins, Steven D. Billings

Open full text 109 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 109 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Merkel cell carcinoma, Merkel cell polyomavirus, Merkel cell, Biology, Cytokeratin, Pathology, Carcinoma, Cancer research

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation — Research Paper | ScholarLens